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Activation of NK cells is a hallmark of infections with intracellular pathogens. We previously
showed that the protozoan parasite Leishmania infantum triggered a rapid NK-cell response
in mice that required TLR9-positive myeloid DC and IL-12, but no IFN-a/b.H e r e ,w ei n v e s -
tigated whether IL-15 or IL-18 mediate the activity of IL-12 or function as independent
activators of NK cells. In contrast to earlier studies that described IL-15 as crucial for NK-cell
priming in response to TLR ligands, the expression of IFN-c, FasL, perforin and granzyme B
by NK cells in L. infantum-infected mice was completely preserved in the absence of IL-15,
whereas the proliferative capacity of NK cells was lower than in WT mice. IFN-c secretion,
cytotoxicity and FasL expression of NK cells from infected IL-18
/ mice were signiﬁcantly
reduced compared with controls, but, unlike IL-12, IL-18 was not essential for NK-cell
effector functions. Part of the NK-cell-stimulatory effect of IL-12 was dependent on IL-18.
We conclude that IL-15 is not functioning as a universal NK-cell priming signal and that
IL-18 contributes to the NK-cell response in visceral leishmaniasis. The cytokine require-
ments for NK-cell activation appear to differ contingent upon the infectious pathogen.
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Introduction
NK cells are important effector cells of the innate immune
response to infectious pathogens and malignant cells. They
contribute to the control of infections and tumors by producing
cytokines such as IFN-g, lysing transformed or virally infected
target cells, and by supporting the development of a protective
T-cell response [1–4]. Later during infection NK cells might also
acquire an immunoregulatory activity [5].
An NK-cell response is readily induced during infections with
intracellular pathogens and requires cytokine and receptor
signals that are delivered by myeloid cells [6–8]. Recently,
myeloid DC (mDC) and neutrophils have been shown to prime
NK cells during viral, bacterial or protozoan infections in vivo
[9–11]. Notably, various cytokines of myeloid cell origin, such as
IFN-a/b [9], IL-12p70 [10], IL-15 [9] and IL-18 [11], were
identiﬁed to account for the activation of mature NK cells. This
suggests that different pathogens might trigger distinct NK-cell
activation pathways, or, alternatively, that the production or
function of the NK-cell-activating cytokines is interdependent so
that the respective gene-deﬁcient mice exhibit a similar defect of
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and independent, but also cooperative effects on NK cells have
been described [11–13]. A particular convincing example for the
sequential action of two cytokines was observed after activation
of NK cells by ligands of TLR3, TLR4, TLR7 or TLR9, which was
strictly dependent on IFN-a/b signaling as well as IL-15. mDC
from WT, but not from IL-15
/ or IFN-a/b-receptor
/ mice
were able to prime NK cells in vitro [14] and in vivo [9]. As TLR-
induced IFN-a/b triggered the production of IL-15 [9, 14, 15], the
IFN-a/b-dependent NK-cell activation is thought to occur via the
release of endogenous IL-15, which binds to the IL-15Ra chain on
the surface of the mDC producer cell and is then transpresented
to IL-15-responsive NK cells expressing the IL-15Rb chain and the
IL-2R common g chain [16, 17]. As IL-15 also cooperates with
IL-18 [18], induces IL-12 by myeloid cells [19, 20], and is
essential for NK-cell expansion and activation during viral,
bacterial and fungal infections [9, 16, 21–26], it can be consid-
ered as a central cytokine not only for normal NK-cell home-
ostasis [17, 27, 28] but also for an active NK-cell response.
When mice are cutaneously or intravenously infected with
protozoan parasites of the species Leishmania (L.) major or
L. infantum, which cause cutaneous or visceral leishmaniasis, NK
cells become rapidly activated in the draining lymph node or
spleen, respectively, and contribute to parasite control (reviewed
in [29]). We previously showed that the activation of NK cells in
these models required mDC, sensing of the parasites by TLR9 and
the release of IL-12, but was independent of IFN-a/b despite
eliciting a strong IFN-a/b response in plasmacytoid DC [10, 30].
These studies, however, did not exclude the contribution of
additional cytokine signals acting independently or up- or
downstream of IL-12. In the present report we therefore
addressed three questions using the mouse model of experi-
mental visceral leishmaniasis: (i) Does IL-15 function as NK-cell-
stimulatory cytokine as predicted from the results obtained in
other systems? (ii) Is IL-18 similar to IL-12 a prerequisite for NK-
cell activation in visceral leishmaniasis? (iii) Do IL-15 and IL-18
operate independently of IL-12? Our data clearly illustrate that
the full induction of NK-cell effector functions in visceral leish-
maniasis requires IL-12 and IL-18, but – unexpectedly – is
entirely independent of IL-15. Whereas IL-12 is essential for the
expression of NK-cell effector functions in vivo, IL-18 only plays a
contributory role by supporting the NK-cell response to IL-12.
Results
Induction of NK-cell effector functions by L. infantum is
independent of IL-15
Considering the known mode of action of IL-15 via transpresen-
tation [16, 17], we ﬁrst tested the expression of the IL-15Ra-
chain on splenic mDC. At 24h after infection with L. infantum, we
observed a 2- to 2.5-fold increase of the percentage of IL-15Ra
1
mDC in the spleen, indicating that L. infantum might modulate
the IL-15/IL-15R system (Supporting Information Fig. 1).
Next, we analysed whether IL-15 is required for the induction
of NK-cell effector functions in vivo. As IL-15 is critical for NK-cell
development and maturation [21, 31], the spleen of IL-15
/
mice contained a dramatically reduced percentage and absolute
number of mature NK cells compared with WT mice
(0.1670.03% versus 2.870.9% NK1.1
1CD3
 cells; mean7SD of
seven or ten experiments, respectively; see also PBS-treated
groups of Fig. 2B). We ﬁrst investigated the L. infantum-induced
expression of IFN-g 12h post infection (p.i.) within the residual
endogenous NK1.1
1CD3
 NK-cell population of IL-15
/ mice as
compared with NK cells of WT controls after a 4h culture period,
either in medium alone or in the presence of YAC-1 target cells.
As expected, the in vitro restimulation augmented the IFN-g
release of in vivo primed NK cells (Fig. 1A). Irrespective of the
culture condition we did not observe a signiﬁcant reduction of the
percentage of IFN-g
1 NK cells in L. infantum-infected mice in the
absence of IL-15; in fact, without YAC cell restimulation the IFN-g
production by NK cells from infected IL-15
/ mice was even
signiﬁcantly higher than by NK cells from WT controls (Fig. 1A,
medium). In contrast, the TLR3-dependent activation of NK cells
elicited by poly(I:C) was drastically reduced in IL-15
/ mice
conﬁrming previously reported results [9]. Thus, IL-15 was
clearly dispensable for the L. infantum-induced expression of
IFN-g by NK cells in vivo.
It was necessary to exclude the possibility that the residual
NK-cell population in IL-15
/ mice had acquired IL-15-inde-
pendent, alternative modes of activation and therefore did not
exhibit the same stimulation requirements as NK cells in WT
mice. To this end we analysed the L. infantum-induced expression
of IFN-g in highly puriﬁed NK cells from uninfected congenic
CD45.1
1 WT donor mice that had been transferred into
L. infantum-infected WT or IL-15
/ recipient mice 2 to 4h after
infection (Fig. 1B and C). As the NK-cell activation was deter-
mined 12h after cell transfer, the duration of the experiment was
short enough to allow for the survival of transferred NK cells in
the IL-15-negative microenvironment. Independent of the in vitro
culture conditions the L. infantum-induced expression of IFN-g in
transferred CD45.1
1 NK cells remained unaffected by the
absence of IL-15 in the recipients. Neither the percentage (Fig. 1B
and C) nor the MFI of IFN-g
1 donor NK cells (WT: 58.2070.49,
IL-15
/: 53.8975.78 (culture in medium); WT: 82.26714.32,
IL-15
/: 74.59716.46 (YAC-1 restimulation); mean7SEM of
three experiments) or the absolute number of IFN-g
1 donor NK
cells (WT: 651799, IL-15
/: 16417324 (culture in medium);
WT: 47337744, IL-15
/: 544471211 (YAC-1 restimulation);
mean7SEM of three experiments) was signiﬁcantly lower in
infected IL-15
/ recipient mice compared with WT controls. In
contrast, the TLR3-dependent activation of NK cells elicited by
poly(I:C) was entirely dependent on IL-15 (Fig. 1B and C).
To test whether IL-15 is required for the induction of NK-cell
cytotoxicity in vivo, we analysed the expression of critical
components of the cytotoxic machinery of NK cells (Fas-FasL
intercellular linkage-mediated pathway; granule-dependent
exocytosis pathway), because the very low number of differ-
entiated NK cells in IL-15
/ mice stymies the direct measurement
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Figure 1. IL-15 is dispensable for NK-cell activation in L. infantum-infected mice. C57BL/6 WT or IL-15
/ mice were injected i.v. with 110
7
L. infantum promastigote parasites or PBS or i.p. with 50mg poly(I:C). (A) Intracellular IFN-g protein expression in endogenous NK cells taken from
WT and IL-15
/ mice at 12h after infection and cultured for 4h in vitro in medium alone or in the presence of YAC-1 cells. Mean7SEM of four
independent experiments with two to three mice per group. (B and C) Intracellular IFN-g protein expression of donor NK cells after transfer into WT
and IL-15
/ mice. Adoptive transfer of CD3
NK1.1
1CD45.1
1 NK cells from naı ¨ve WT donor mice was performed 2–4h after L. infantum infection,
PBS or poly(I:C) treatment of CD45.2
1 WT or IL-15
/ recipients. Twelve hours later splenocytes were prepared, cultured in medium or in the
presence of YAC-1 cells for 4h, and stained for CD3
NK1.1
1CD45.1
1 NK cells and intracellular IFN-g. (B) Dot plot analysis of one representative of
three experiments with two to three mice per group after in vitro restimulation with YAC-1 cells is given. (C) Mean7SEM of three independent
experiments with two to three mice per group. (D) Surface expression of FasL and intracellular expression of perforin or gzmB of endogenous
CD3
NK1.1
1 NK cells from WT and IL-15
/ directly ex vivo. Mean7SEM of three to four experiments with two to three mice per group. (A–D)
Signiﬁcant differences by Mann–Whitney test between cells from infected, poly(I:C) or IL-15-treated and PBS-treated mice (p o 0.05; p o 0.002) and
between WT and IL-15
/ (
]po0.05;
]]p o 0.005) are indicated.
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Figure 2. Infection with L. infantum causes an IL-15-dependent NK-cell proliferation, which does not augment the splenic NK-cell compartment.
110
7 L. infantum promastigote parasites or PBS were injected i.v. in C57BL/6 WTor IL-15
/ mice. (A) NK-cell proliferation in WTand IL-15
/ mice
24h upon infection, poly(I:C) or IL-15/sIL-15Ra treatment measured by BrdU incorporation. Twenty-two hours p.i. 1mg BrdU per mouse was
injected i.p. and 2h later the percentage of proliferated BrdU
1 NK cells was analysed by FACS. Mean7SEM of two independent experiments with
two mice per group. Signiﬁcant differences by Mann–Whitney test between cells from infected, poly(I:C) or IL-15-treated and PBS treated mice
(p o 0.05; p o 0.002) and between WTand IL-15
/ (
]po0.05;
]]po0.005) are indicated. (B) Absolute NK1.1
1CD3
 NK-cell numbers in the spleen were
determined by FACS analysis at days 1 and 4 of infection. Mean7SEM of three independent experiments with two to three mice per group is given.
Signiﬁcant differences by Mann–Whitney test between cells from poly(I:C) and PBS treated mice (p o 0.05) are indicated.
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of the percentages of FasL
1, perforin
1 and granzyme (gzm) B
1
NK cells in the spleen, which was indistinguishable in WT and
IL-15
/ mice, whereas the induction of perforin and gzmB in
response to poly(I:C) was clearly impaired in NK cells from
IL-15
/ mice (Fig. 1D). Thus, the induction of both NK-cell
effector functions (IFN-g release and cytotoxicity) by L. infantum
is completely preserved in the absence of IL-15.
IL-15-dependent proliferation of NK cells in
L. infantum-infected mice
Since signals through the IL-2Rg/IL-15Rb on NK cells are
also known to stimulate NK-cell proliferation and accumulation
[17, 22, 24, 32, 33], we tested the NK-cell expansion in
L. infantum-infected WT versus IL-15
/ mice 24h p.i. by BrdU
incorporation. As a positive control both mouse groups were
treated i.p. with pre-complexed IL-15 and sIL-15R-Fc, a ‘‘super-
agonist’’ of NK-cell proliferation [34]. The injection of the
parasites triggered a small, but signiﬁcant NK-cell proliferation
in the spleen of WT mice during the ﬁrst day of infection, which
was not observed in the absence of IL-15 (Fig. 2A). The
L. infantum-induced and IL-15-dependent NK-cell proliferation,
however, did not lead to an expansion of the splenic NK-cell
compartment. During the early phase of infection (day 1 until day
4) the absolute number of NK cells per spleen remained unaltered
in both WT and IL-15
/ mice compared with the respective
uninfected control mice (Fig. 2B). In contrast, poly(I:C) treat-
ment caused an IL-15-dependent decrease of the splenic NK-cell
number, which presumably reﬂects the migration of primed and
activated NK cells to the periphery [9].
The activation of NK cells in IL-15
/ mice requires
IL-12
Having seen that IL-15 is dispensable for induction of NK-cell
effector functions by L. infantum, we addressed the question,
whether the L. infantum-induced NK-cell response in IL-15
/
mice is still strictly dependent on IL-12 as seen in WT mice [10]
(see also below in text and Fig. 4). We ﬁrst checked the secretion
of IL-12 by splenic mDC of WT and IL-15
/ mice following
infection (Fig. 3A). In both mouse groups IL-12 was induced
upon infection, although mDC-derived IL-12p40/p70 was slightly
reduced in IL-15-deﬁcient mice at the 12h time point. The fact
that this difference was no longer detectable at 24h p.i. (Fig. 3A)
argues against a profound and biologically relevant difference in
the production of IL-12 by mDC of both mouse strains. This view
is strongly supported by the fact that in all our NK-cell transfer
experiments (see Fig. 1C) the percentage of IL-12p40/p70
1
splenic mDC (4–5%) 14–16h p.i. was comparable in infected
WT and IL-15
/ mice (data not shown). Furthermore, neutra-
lization of IL-12 by Ab-treatment prior to infection completely
prevented NK cell IFN-g production in both WT and
IL-15
/ mice (Fig. 3B). Anti-IL-12 had exactly the same effect,
when the NK cell IFN-g expression was determined without in
vitro restimulation, except that the percentages of IFN-g
1 NK cells
were lower in all groups (data not shown). Thus, even under IL-
15-deﬁcient conditions IL-12 is the key cytokine for L. infantum-
induced NK-cell activation.
Endogenous IL-18 contributes to the activation of NK
cells in visceral leishmaniasis
As IL-18 is known to activate mouse NK cells in vitro and in vivo
[12, 35], we tested whether IL-18 contributes to the NK-cell
activation in visceral leishmaniasis. At the height of innate IFN-g
production in the spleen (12h p.i.) the percentage of IFN-g
A
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Figure 3. Activation of NK cells in IL-15
/ mice strictly depends on
IL-12. C57BL/6 WT, IL-15
/ or IL-18
/ mice were injected i.v. with
110
7 L. infantum promastigote parasites or PBS. (A) Intracellular
IL-12p40/p70 expression in splenic mDC (CD11b
intCD11c
hi cells) taken
from WT and IL-15
/ mice at 12 or 24h after infection and cultured
in vitro for 4h in medium. Three independent experiments with two to
three mice per group. Each diamond represents a single mouse; the
mean is given as horizontal line. (B) Intracellular IFN-g protein
expression in NK cells taken from WT, IL-15
/ or IL-18
/ mice 12h
after infection and co-cultured for 4h in vitro with YAC-1 cells; 30min
before injection of parasites or PBS IL-12p40-neutralizing mAb or rat
IgG control Ab were applied i.p. Mean7SEM of two independent
experiments with two mice per group. Signiﬁcant differences by
Mann–Whitney test between anti-IL-12p40 and control IgG treatment
are indicated as p o 0.05; between WT and IL-15
/ or IL-18
/ NK cells
as
]p o 0.05.
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Figure 4. Mechanism of NK-cell activation by IL-18 in L. infantum-infected mice. At 12 and 24h after i.v. injection of PBS or L. infantum
promastigotes into C57BL/6 WT, IL-18
/ and IL-12p35
/ mice, splenocytes were prepared. (A) Frequency of IFN-g
1 NK cells (CD3
NK1.1
1)a s
determined by intracellular cytokine staining and FACS analysis after a 4h culture in medium or with YAC cells. Mean7SEM of six (WT versus
IL-18
/) and three (WT versus IL-18
/ and IL-12p35
/) independent experiments with two to three mice per group. (B) NK-cell cytotoxicity at 24h
after infection. Mean7SEM of four (WT versus IL-18
/) and three (WT versus IL-18
/ and IL-12p35
/) independent experiments with two to three
mice per group. (C) Intracellular IL-12p40/p70 protein expression of splenic mDC (restimulated in culture medium for 4h; gated on CD11b
intCD11c
hi
cells) is shown in a dot plot analysis representative for three independent experiments with two to three mice per group. (D) Surface expression of
IL-12Rb1 on CD3
-NK1.1
1 NK cells directly ex vivo. Mean7SEM of three experiments with two to three mice per group. (E) Intracellular IFN-g protein
expression in NK cells from WTand IL-18
/ mice 12h after infection or PBS treatment, which were cultured for 4h (7IL-18), washed, and further
incubated for 15h (7IL-12). Mean7SEM of three independent experiments with two mice per group. (F) Surface expression of FasL and intracellular
expression of perforin or gzmB of CD3
-NK1.1
1 NK cells directly ex vivo. FasL: mean7SEM of ﬁve (WT versus IL-18
/) and three (WT versus IL-18
/
and IL-12p35
/) experiments, two to three mice per group; perforin: mean7SEM of three experiments, two mice per group; gzmB: mean7SEM of
four (WT versus IL-18
/) and three (WT versus IL-18
/ and IL-12p35
/) experiments, two to three mice per group. (A–F) Signiﬁcant differences by
Mann–Whitney test between cells from infected and PBS treated mice (p o 0.05; p o 0.002) and between WT and IL-18
/ or IL-12p35
/ (
]p o 0.05;
]]p o 0.005) are indicated.
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/ mice was reduced by
roughly 50% compared with WT mice (with or without in vitro
restimulation) (Fig. 4A). Notably, infection with L. infantum did
lead to an upregulation of IFN-g mRNA in partially (70%) or
highly puriﬁed splenic NK cells (>99.9%) and the levels of IFN-g
mRNA were comparable in WT and IL-18
/ mice (Supporting
Information Fig. 2; data not shown). The cytotoxic activity
of NK cells from IL-18
/ mice was signiﬁcantly lower compared
with WT NK cells (Fig. 4B). As seen before [10] the IFN-g
production as well as the cytotoxic activity of NK cells in
L. infantum-infected IL-12
/ mice was nearly completely
blocked (Fig. 4A and B). Thus, NK-cell activation is partially
maintained in IL-18
/ mice, but abolished in IL-12
/ mice.
Functional relationship between IL-12 and IL-18
during activation of NK cells in visceral
leishmaniasis
Earlier studies, which used naı ¨ve, non-infected mice, proposed
that IL-18 either acts on NK cells in an IL-12-independent manner
or that it increases the IL-12 responsiveness of NK cells [12, 13].
We therefore performed experiments to deﬁne how IL-18 might
promote the IFN-g production and the cytotoxicity of NK cells in
visceral leishmaniasis. First, we searched for a possible impact of
IL-18 on the expression of IL-12, which is essential for NK-cell
activation in L. infantum-infected mice [10]. We obtained no
evidence that IL-18 regulates the induction of IL-12 by
L. infantum in splenic DC in vivo (Fig. 4C) or in BM-derived DC
or macrophages in vitro (Supporting Information Fig. 3), thus
excluding the possibility that IL-18 functions via increasing the
availability of IL-12. Second, we observed that the surface
expression of the IL-12Rb1-chain and the mRNA expression of
IL-12Rb2-chain of NK cells from WT and IL-18
/ mice were
comparable (Fig. 4D and Supporting Information Fig. 4), which
argues for an IL-12R-independent effect of IL-18. Third, we tested
whether IL-18 might prime NK cells from L. infantum-infected
mice for a response to IL-12 as previously reported for naı ¨ve mice
[13]. For this purpose spleen cells were harvested from PBS-
treated or L. infantum-infected WT or IL-18
/ mice 12h p.i. and
cultured in the presence or absence of IL-18 for 4h, followed by a
15h incubation with or without IL-12. Thereafter, the IFN-g
production of NK cells was measured. Conﬁrming earlier results
[13], the in vitro induction of IFN-g in naı ¨ve NK cells by IL-12
required prior in vivo priming by IL-18. In NK cells from IL-18
/
mice the IFN-g expression could be restored by in vitro pre-
stimulation with IL-18, which further augmented the IFN-g
release by NK cells of both mouse strains. Identical results were
obtained with NK cells from infected mice (Fig. 4E). These ex vivo
data suggest that priming by IL-18 is required to achieve full
IL-12-mediated NK-cell activity during the early phase of
L. infantum infection. However, it is important to emphasize that
the induction of NK cell IFN-g secretion and NK-cell cytotoxicity
in vivo were only partially blocked in IL-18
/ mice, whereas
both NK-cell functions were almost completely abolished in the
absence of IL-12 (Fig. 4A and B). In addition, the production of
IFN-g by NK cells from IL-18
/ mice was eliminated when IL-12
was neutralized (Fig. 3B). Finally, we investigated whether IL-18
regulates FasL, perforin and/or gzmB expression. Although
L. infantum infection caused an increase of the percentages of
FasL
1 NK cells in the spleen of both WT and IL-18
/ mice, the
numbers of FasL
1 NK cells were signiﬁcantly lower in the case of
IL-18
/ mice (Fig. 4F). In contrast, a deﬁciency of IL-18 did not
affect the expression of gzmB or perforin mRNA and protein
in NK cells (Fig. 4F and Supporting Information Fig. 5). In
IL-12
/ mice none of these cytotoxic effector molecules was
induced upon infection (Fig. 4F).
Together, these data support the notion that IL-18 contributes
to the IL-12-mediated NK cell IFN-g response by increasing the
IL-12 responsiveness of NK cells. In addition, the results clearly
illustrate that IL-12 also exerts IL-18-independent NK-cell-
stimulatory effects.
Discussion
We previously reported an essential role of mDC-derived IL-12 for
NK-cell activation in visceral leishmaniasis, whereas IFN-a/b was
largely dispensable [10]. In the present study we provide novel
insights into the cytokine signals and mechanisms that underlie
the process of NK-cell activation during L. infantum infection.
First, our results demonstrate that the IL-12-dependent stimula-
tion of NK cell IFN-g production and cytotoxicity did not require
the activity of IL-15 as shown by the analysis of residual NK cells
in IL-15
/ mice or the transfer of WT NK cells into L. infantum-
infected IL-15
/ mice. Only the modest enhancement of
NK-cell proliferation in L. infantum-infected mice was mediated
by IL-15. Second, even in the strict absence of IL-15 no
compensatory IL-12-independent mechanism for the activation
of NK-cell effector functions emerged. Third, IL-18 helped
to trigger NK-cell effector functions in L. infantum infection,
but comparing the NK-cell response in WT, IL-12
/ and
IL-18
/ mice it became readily apparent that IL-18 played a
contributory, but not an essential role. Finally, in vivo and ex vivo
experiments demonstrated that IL-18 facilitated the response of
NK cells to IL-12, but also proved that IL-12 is capable to
stimulate NK cells in the absence of IL-18. There was clearly a
differential regulation of FasL, perforin and gzmB in IL-18
/
versus IL-12
/ mice.
The IL-18-independent effect of IL-12 on NK-cell activation in
visceral leishmaniasis might result from an increased nuclear
translocation of STAT4 and/or NF-kB as previously seen in NK
cells present in unseparated mouse macrophage populations
[36, 37]. The enhancement of NK-cell cytotoxicity by IL-18 in
L. infantum-infected mice is most likely due to the observed
increased FasL-expression, which was shown to account for the
antitumor effects of a treatment with IL-18 [38, 39].
Our results contrast with earlier ﬁndings obtained in other
infection models using viral, bacterial or fungal pathogens, where
IFN-a/b and/or IL-15 enhanced the activation of NK cells or were
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toxicity [1, 9, 22, 25, 26]. With respect to the regulation of the
expression of NK-cell cytotoxic granule proteins Fehniger
et al. identiﬁed IL-2 and IL-15 as cytokines that were most potent
in switching on the translation of perforin and gzmB in
mouse NK cells in vitro, whereas IL-12 showed only a mild effect
[40]. These data differ markedly from our in vivo observations in
visceral leishmaniasis, where we noted a strictly IL-12-dependent,
but IL-15-independent increase of perforin and gzmB protein in
NK cells (Figs. 1D and 4F). In accordance with earlier in vitro
studies [40] our data provide evidence that perforin and gzmB
are regulated by a post-transcriptional mechanism also in vivo,
because up-regulation of both molecules was only visible on the
protein level, but not on the mRNA level (Fig. 4F and Supporting
Information Fig. 5).
There is evidence that an IL-15-independent activation of NK
cells might also occur during other protozoan infections.
Although the necessary in vivo experiments have not yet been
reported, at least in vitro splenic DC from Plasmodium chabaudi-
infected IL-15
/ mice were as potent as DC from WT mice to
activate partially puriﬁed NK cells for the expression of IFN-g
[41]. Even during certain viral infections IL-15 might be
dispensable for NK-cell activation. During the preparation of our
manuscript Sun et al. published that an infection with mouse
CMV (MCMV) elicits a massive expansion of NK cells (72-fold
within 7 days) in IL-15Ra-deﬁcient mice and that these NK cells
can be activated in vitro for the expression of IFN-g and target cell
cytotoxicity [42]. As shown in the present study, L. infantum also
caused a proliferation of NK cells (Fig. 2A), but unlike to the
MCMV model it required IL-15 and did not lead to a measurable
expansion and accumulation of NK cells in the spleen (Fig. 2B).
This is most likely due to several circumstances. First, the NK-cell
proliferation induced by L. infantum was quite weak. Only
approximately 2.5% of all NK cells incorporated BrdU during the
ﬁnal 2h of a 24h infection period, whereas in the MCMV model a
vigorous NK-cell proliferation with 21% BrdU
1 NK cells was
reported at day 1.5 of infection [43]. Second, the modest NK-cell
proliferation conveyed by IL-15 might reﬂect the less than
twofold upregulation of the expression of IL-15Ra on mDC at day
1o fLeishmania infection (Supporting Information Fig. 1). Third,
in the viral model the proliferation of the NK cells in the
absence of IL-15 (or IFN-a/b) was maintained by the activating
NK-cell receptor Ly49H, which is directly targeted by a single,
highly stimulatory viral glycoprotein m157, and by IL-12
[42, 43]. Although surface lipophosphoglycan puriﬁed from
L. major was reported to activate human NK cells in vitro [44], we
obtained no evidence for a direct activation of NK cells by
L. infantum parasites [10]. In fact, recent data suggest that
Leishmania parasites might even express surface molecules that
directly suppress NK-cell proliferation [45].
In conclusion, our analysis of the early NK-cell effector
response in visceral leishmaniasis revealed differential functions
for the cytokines IL-12, IL-15 and IL-18. In contrast to other
models, IL-15 was required for NK-cell proliferation, but not for
the IL-12-dependent NK cell IFN-g production and cytotoxicity.
We propose that the NK-cell effector response elicited by different
pathogens in vivo requires distinct sets of cytokine signals and
does not converge on a single or dominant NK-cell activation
pathway.
Materials and methods
Mice, parasites and infection
Female C57BL/6 mice were obtained from Charles River
(Sulzfeld, Germany). IL-12p35
/ [46], IL-18
/ [35] (both
on a C57BL/6 background) and B6.SJL-Ptprc
aPepc
b/BoyJ
(CD45.1
1) mice were from the Jackson Laboratories (Bar
Harbor, ME, USA). IL-15
/ mice [31] (C57BL/6 background)
were purchased from Taconic (Germantown, NY, USA). All mice
were housed under speciﬁc pathogen-free conditions and used at
the age of 6–16wk.
The origin, propagation and preparation of L. infantum
promastigotes (strain MHOM/00/98/LUB1) were described
before [10].
Mice were injected into the retro-orbital plexus with 300mL
PBS or 110
7 stationary-phase L. infantum promastigotes in
300mL PBS. The animal experiments were approved by the
governmental animal welfare committee.
Generation, puriﬁcation and stimulation of DC and
macrophages
Preparation of splenic mDC, generation of BMMF and BM-mDC
and cultivation of the cells was performed as described [10, 37].
For stimulation CpG ODN 1668 (1mM, Thermo Electron, Ulm,
Germany) and L. infantum promastigotes (parasite:cell ratio
(MOI) indicated in the text) were used.
Flow cytometry analysis and intracellular cytokine
staining
For surface phenotyping and cell sorting the following ﬂuor-
ochrome (FITC-, PE-, PerCP or APC)-labeled or biotinylated mAb
were used (all from BD Biosciences, Heidelberg, Germany, unless
otherwise stated): anti-CD11b (M1/70), anti-CD11c (HL3), anti-
I-A/I-E (M5/114.15.2), anti-F4/80 (CI:A3-1, AbD Serotec,
Du ¨sseldorf, Germany), anti-IL-15Ra (BAF551, R&D Systems,
Wiesbaden, Germany), anti-NK1.1 (PK136), anti-NKp46
(29A1.4; eBioscience, Hatﬁeld, UK), anti-CD45.1 (A20), anti-
CD3 (145–2C11), anti-IL12Rb1 chain (114) and anti-FasL
(MFL3). The speciﬁcity of the stainings was veriﬁed by the use
of isotype control mAb. PI was included at 1mg/mL in the ﬁnal
wash to detect dead cells.
The intracellular cytokine staining of IFN-g in splenic NK cells
or of IL-12p40/70 in splenic CD11b
intCD11c
1 cells was
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medium alone or with YAC-1 cells in the presence of brefeldin A
[10]. In some experiments splenocytes were restimulated
in vitro with rmIL-18 (10ng/mL, R&D Systems) for 4h, washed
three times with PBS and stimulated with rmIL-12 (1ng/mL,
R&D Systems) for further 15 h before analysis of intracellular
IFN-g expression in NK cells [10]. The intracellular expression of
gzmB and perforin in splenic NK cells was measured by anti-
gzmB (16G6, eBioscience) and anti-perforin (eBioOMAK,
eBioscience) directly ex vivo. All FACS analyses were run on a
FACS Calibur
s (BD Biosciences) using the Cell Quest Pro
s
software.
NK-cell proliferation in vivo
To investigate cell proliferation in vivo the thymidine analog
BrdU (1mg/mouse) was injected i.p. into L. infantum-infected,
IL-15/sIL-15R-Fc- or poly(I:C)-treated or control mice 22h p.i.,
respectively. Two hours later the number of cells that incorpo-
rated BrdU into the DNA during proliferation was determined via
the APC BrdU Flow Kit (BD Biosciences) according to the
manufacturer’s instructions.
NK-cell cytotoxicity assay
After determination of the percentage of NK1.1
1CD3
 or NKp46
1
CD3
 NK cells within whole spleen cells, the NK-cell cytotoxicity
against YAC-1 tumor cells was determined in a standard
chromium-51 release assay [10].
NK-cell transfer and in vivo treatments
For cell transfer experiments splenic NK cells of CD45.1
1
C57BL/6 mice were puriﬁed by MACS technology using anti-
DX5 MicroBeads (Miltenyi, Bergisch-Gladbach, Germany) and by
subsequent MoFlo
s sorting gating on NK1.1
1CD3
 cells (purity
Z99%). Puriﬁed NK cells were injected i.v. For activation of NK
cells in vivo, mice received 50mg poly(I:C) (Invivogen, Toulouse,
France) i.p. For neutralization of IL-12 mice were injected with
100mg rat anti-IL-12p40mAb (C17.8, eBioscience) or control rat
IgG (The Jackson Laboratory) 30min before i.v. infection with
L. infantum. As positive control for the NK-cell proliferation assay
mice were injected i.p. with pre-complexed 0.5mg/mouse huIL-15
and 3mg/mouse sIL-15Ra-Fc (both R&D Systems) as described
[34].
mRNA expression analysis
Total RNA of homogenized tissue or of puriﬁed cells was
extracted using the TRIZOL reagent (Invitrogen, Karlsruhe,
Germany) or the RNeasy Micro Kit (Qiagen, Hilden, Germany)
and was reverse transcribed using the High Capacity
cDNA Archive Kit (Applied Biosystems, Darmstadt, Germany).
To assess the amount of mRNA expression levels we
exactly followed our previously described protocol [30]. The
following assays (Applied Biosystems) were used: murine
hypoxanthine guanine phosphoribosyl transferase 1 (mHPRT-1)
(Mm00446968_m1), mIFN-g (Mm00801778_m1), perforin
(Mm00812512_m1), gzmB (Mm00442834_m1) and IL-12Rb2
(Mm00434200_m1).
Statistical analysis
The non-parametric Mann–Whitney test was performed where
indicated and p values are given.
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